Clin2
NCT05545371Possibly a fitEnrolling by invitation

Rabies prevention vaccine shots for ages 10 to 60

Rabies HumanAntibody

Part of Infections clinical trials.

This trial tests whether giving four rabies vaccine doses can prevent rabies infection. You may be able to join if you’re in the right age range and have no history of rabies vaccine or certain immune system conditions.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
2,100 people
Ages
10 years to 60 years
Study type
Interventional

Who can take part

  • Be between 10 and 60 years old
  • Your temperature on the day you enroll must be below 37.3°C
  • Do not have a past history of receiving rabies vaccines
  • Do not use rabies ‘passive protection’ medicines (given as antibodies after exposure)
  • Do not have immune system problems (immunodeficiency) or autoimmune diseases
  • If you’re pregnant, breastfeeding, or planning a birth during the study, you cannot join

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07338786Enrolling by invitation· Phase 1
Rabies vaccine safety trial for ages 10 to 60

This trial tests a freeze-dried rabies vaccine to see how safe it is when given on different schedules. It may be an option for people who need protection from rabies.

Xuzhou, Jiangsu
NCT07021703Recruiting· Phase 1
Rabies vaccine trial for people aged 10 to 60

This trial tests a new rabies vaccine to see if it's safe and effective. It's for people who haven't been vaccinated against rabies or been bitten by a rabies-risk animal recently.

Zhengzhou, Henan
NCT07500207Enrolling by invitation· Phase 3
Rabies vaccine trial for people aged 10 to 60

This trial tests a new lyophilized rabies vaccine to see how well it works and how safe it is. It is for people who have not been vaccinated against rabies recently and have not been bitten or scratched by an animal that broke the skin in the past year.

Neijiang, Sichuan
NCT07028801Not yet recruiting· Phase 3
Testing a new rabies vaccine for people

This trial tests a new freeze-dried rabies vaccine made from human cells. It is for people who may need protection against rabies after a possible exposure, and the study will compare it to standard rabies vaccines.

Zhengzhou, Henan
NCT07445815Not yet recruiting· Phase 2
Testing a new rabies antibody in healthy adults

This trial tests a new lab-made antibody to prevent rabies after exposure. It is for healthy volunteers who have not gotten a rabies vaccine or been exposed to rabies before.

Lanzhou, Gansu
NCT07416110Not yet recruiting· Phase 3
Rabies vaccine lot consistency trial for healthy adults

This trial tests whether different batches of an experimental rabies vaccine work the same way. It is for healthy adults aged 18 to 45 who have not been exposed to rabies or received rabies treatment before.

Deyang

Hear when a new Antibody trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.